4.7 Article

The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Infectious Diseases

Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy

Alexandre P. Zavascki et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2010)

Article Infectious Diseases

Polymyxin B and colistimethate are comparable as to efficacy and renal toxicity

Maura S. Oliveira et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)

Article Infectious Diseases

Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections

Ayse Erbay et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)

Article Immunology

Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients

Alexandre P. Zavascki et al.

CLINICAL INFECTIOUS DISEASES (2008)

Letter Infectious Diseases

Intravenous colistimethate for multidrug-resistant: Gram-negative bacteria

Alexandre P. Zavascki et al.

LANCET INFECTIOUS DISEASES (2008)

Review Infectious Diseases

Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review

Alexandre Prehn Zavascki et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)

Review Infectious Diseases

Polymyxin B: similarities to and differences from colistin (polymyxin E)

Andrea Kwa et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2007)

Article Infectious Diseases

In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates

Roxanne J. Owen et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)

Review Critical Care Medicine

Toxicity of polymyxins: a systematic review of the evidence from old and recent studies

Matthew E. Falagas et al.

CRITICAL CARE (2006)

Article Microbiology

Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa

VH Tam et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)

Article Microbiology

Pseudomonas aeruginosa bloodstream infection:: Importance of appropriate initial antimicrobial treatment

ST Micek et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)